Transfusional Iron Overload: Further Reading

Note: Canadian Blood Services offers no endorsement of and assumes no liability for the currency, accuracy, or availability of any information on these sites.

1. Ballas SK. Iron overload is a determinant of morbidity and mortality in adult patients with sickle cell disease. Semin Hematol 2001 Jan.;38(1 Suppl 1)30-6. [ Medline ]
2. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR: Thalassemia Clinical Research Network. Complications of beta-thalassemia major in North America. Blood. 2004 Jul 1; 104(1): 34-9. [Medline]
3. Harmatz P, Butensky E, Quirolo K, Williams R, Ferrell L, Moyer T, et al. Severity of iron overload in patients with sickle cell disease receiving chronic red blood cell transfusion therapy. Blood 2000 Jul.1;96(1): 76-9.
4. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology (Am Soc Hematol Educ Program) 2001 Jan.; 47-61.
5. Olivieri NF. Progression of iron overload in sickle cell disease. Semin Hematol. 2001 Jan.;38(1 Suppl 1):57-62. [ Medline ]